<DOC>
	<DOCNO>NCT01070329</DOCNO>
	<brief_summary>The purpose study find 60 mg duloxetine give day mouth 8 week patient diagnose major depressive disorder , also report associate painful physical symptom , good placebo treat depression associate painful symptom .</brief_summary>
	<brief_title>A Study Depression Associated Painful Physical Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Key Meets criterion Major Depressive Disorder ( MDD ) define Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) confirm Mini International Neuropsychiatric Interview ( MINI ) MontgomeryAsberg Depression Rating Scale ( MADRS ) total score great equal 20 Screening Phase At least 1 previous episode depression Painful physical symptom score great equal 3 Brief Pain InventoryShort Form ( BPISF ) average pain question A Clinical Global Impression Severity ( CGIS ) score great equal 4 Screening Phase Written inform consent Key Currently enrol , discontinue within last 30 day , clinical trial involve offlabel use investigational drug device Have previously complete withdrawn study study investigate duloxetine ( unless study drug receive ) Women childbearing potential use medically accept mean contraception Have current ( within past 6 month ) DSMIVTR primary Axis I diagnosis MDD Have history alcohol abuse and/or substance abuse dependence within 1 year prior screen study Have prior history bipolar disorder , psychosis , schizophrenia Have Axis II disorder would interfere study compliance Lack response episode major depression ( lifetime subject ) two adequate course antidepressant therapy , clinically appropriate dose least 4 week , alternatively , judgment investigator , subject meet criteria treatment resistant depression Have previously receive treatment MDD Generalized Anxiety Disorder ( GAD ) adequate trial duloxetine respond could tolerate duloxetine Diagnosis acute liver injury severe cirrhosis Uncontrolled narrowangle glaucoma Positive urine drug screen substance abuse Have serious medical illness , include cardiovascular , hepatic , renal , respiratory , hematologic , endocrinologic , neurologic disease , clinically significant laboratory abnormality stabilize anticipated require intervention , hospitalization , use exclude medication study History serious suicide attempt subject judge clinically serious suicidal risk Requires continuous use analgesic 6 month chronic pain Has pain know origin Meets criteria fibromyalgia define American College Rheumatology Experiences great equal 1 migraine headache per week Have electroconvulsive therapy ( ECT ) , transcranial magnetic stimulation ( TMS ) , vagus nerve stimulation ( VNS ) within 1 year prior screen study Initiating , change , stop psychotherapy within 6 week prior screen study time study Investigator subject anticipates initiate , change , stop nonpharmacologic alternative therapy painful physical symptom time study Are take excluded medication within 7 day prior randomization exception fluoxetine take within 30 day prior randomization Treatment monoamine oxidase inhibitor ( MAOI ) within 14 day prior randomization potential need use MAOI study within 5 day discontinuation study drug Abnormal thyroid stimulate hormone Has epilepsy history seizure disorder receive treatment anticonvulsant medication epilepsy seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>